Safety Considerations in Assessing the Role of Immunotherapy in Allergic Disorders
- 1 January 1994
- journal article
- review article
- Published by Springer Nature in Drug Safety
- Vol. 10 (1) , 5-17
- https://doi.org/10.2165/00002018-199410010-00002
Abstract
No abstract availableKeywords
This publication has 92 references indexed in Scilit:
- Immunotherapy with a standardized Dermatophagoides pteronyssinus extractJournal of Allergy and Clinical Immunology, 1989
- Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids I. Rush immunotherapy with allergoids and standardized orchard grass-pollen extractJournal of Allergy and Clinical Immunology, 1987
- Clinical and immunologic evaluation of tyrosine-adsorbed extract: A double-blind placebo-controlled trialJournal of Allergy and Clinical Immunology, 1984
- Controlled evaluation of allergoid in the immunotherapy of ragweed hay feverJournal of Allergy and Clinical Immunology, 1982
- Rush venom immunotherapy program for honeybee sting sensitivityJournal of Allergy and Clinical Immunology, 1979
- A Controlled Trial of Immunotherapy in Insect HypersensitivityNew England Journal of Medicine, 1978
- Allergen injection therapy with glutaraldehyde-modified—ragweed pollen-tyrosine adsorbateJournal of Allergy and Clinical Immunology, 1977
- Immunotherapy of hay fever with ragweed antigen E: Comparisons with whole pollen extract and placebosJournal of Allergy, 1968
- Hyposensitization therapy including repository: A double-blind studyJournal of Allergy, 1964
- The risk of inducing constitutional reactions in allergic patientsJournal of Allergy, 1957